ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.

Stephen Boulton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.